Implantation of Prophylactic Nonabsorbable Intraperitoneal Mesh in Patients With Peritonitis Is Safe and Feasible

被引:44
|
作者
Kurmann, Anita [1 ]
Barnetta, Corina [1 ]
Candinas, Daniel [1 ]
Beldi, Guido [1 ]
机构
[1] Univ Bern, Inselspital, Univ Hosp Bern, Dept Visceral Surg & Med, CH-3010 Bern, Switzerland
关键词
RANDOMIZED CLINICAL-TRIAL; HERNIA REPAIR; RISK-FACTOR; ANEURYSM;
D O I
10.1007/s00268-013-2019-4
中图分类号
R61 [外科手术学];
学科分类号
摘要
Patients with peritonitis undergoing emergency laparotomy are at increased risk for postoperative open abdomen and incisional hernia. This study aimed to evaluate the outcome of prophylactic intraperitoneal mesh implantation compared with conventional abdominal wall closure in patients with peritonitis undergoing emergency laparotomy. A matched case-control study was performed. To analyze a high-risk population for incisional hernia formation, only patients with at least two of the following risk factors were included: male sex, body mass index (BMI) > 25 kg/m(2), malignant tumor, or previous abdominal incision. In 63 patients with peritonitis, a prophylactic nonabsorbable mesh was implanted intraperitoneally between 2005 and 2010. These patients were compared with 70 patients with the same risk factors and peritonitis undergoing emergency laparotomy over a 1-year period (2008) who underwent conventional abdominal closure without mesh implantation. Demographic parameters, including sex, age, BMI, grade of intraabdominal infection, and operating time were comparable in the two groups. Incidence of surgical site infections (SSIs) was not different between groups (61.9 vs. 60.3 %; p = 0.603). Enterocutaneous fistula occurred in three patients in the mesh group (4.8 %) and in two patients in the control group (2.9 %; p = 0.667). The incidence of incisional hernia was significantly lower in the mesh group (2/63 patients) than in the control group (20/70 patients) (3.2 vs. 28.6 %; p < 0.001). Prophylactic intraperitoneal mesh can be safely implanted in patients with peritonitis. It significantly reduces the incidence of incisional hernia. The incidences of SSI and enterocutaneous fistula formation were similar to those seen with conventional abdominal closure.
引用
收藏
页码:1656 / 1660
页数:5
相关论文
共 50 条
  • [1] Implantation of Prophylactic Nonabsorbable Intraperitoneal Mesh in Patients With Peritonitis Is Safe and Feasible
    Anita Kurmann
    Corina Barnetta
    Daniel Candinas
    Guido Beldi
    World Journal of Surgery, 2013, 37 : 1656 - 1660
  • [2] Implantation of prophylactic non-absorbable intraperitoneal mesh in patients with peritonitis is safe and feasible
    Kurmann, Anita
    Barnetta, Corina
    Candinas, Daniel
    Beldi, Guido
    SWISS MEDICAL WEEKLY, 2012, 142 : 16S - 16S
  • [3] Prophylactic, Synthetic Intraperitoneal Mesh Versus No Mesh Implantation in Patients with Fascial Dehiscence
    Manuel O. Jakob
    Daniel Spari
    Joel Zindel
    Tawan Pinworasarn
    Daniel Candinas
    Guido Beldi
    Journal of Gastrointestinal Surgery, 2018, 22 : 2158 - 2166
  • [4] Prophylactic, Synthetic Intraperitoneal Mesh Versus No Mesh Implantation in Patients with Fascial Dehiscence
    Jakob, Manuel O.
    Spari, Daniel
    Zindel, Joel
    Pinworasarn, Tawan
    Candinas, Daniel
    Beldi, Guido
    JOURNAL OF GASTROINTESTINAL SURGERY, 2018, 22 (12) : 2158 - 2166
  • [5] Prophylactic intraperitoneal onlay mesh (IPOM) is feasible and safe and prevents incisional hernias - short-term results of a randomized controlled trial
    Brosi, P.
    Glauser, P.
    Kissling, P.
    Zschokke, I.
    Maurer, C. A.
    BRITISH JOURNAL OF SURGERY, 2013, 100 : 14 - 14
  • [6] Prophylactic intraperitoneal mesh implantation for prevention of incisional hernia: A randomized controlled trial
    Kohler, A.
    Lavanchy, J.
    Kurmann, A.
    Candinas, D.
    Beldi, G.
    BRITISH JOURNAL OF SURGERY, 2017, 104 : 9 - 9
  • [7] PROPHYlactic Implantation of BIOlogic Mesh in peritonitis (PROPHYBIOM): a prospective multicentric randomized controlled trial
    F. Coccolini
    A. Tarasconi
    G. L. Petracca
    G. Perrone
    M. Giuffrida
    C. Disisto
    M. Sartelli
    P. Carcoforo
    L. Ansaloni
    F. Catena
    Trials, 23
  • [8] PROPHYlactic Implantation of BIOlogic Mesh in peritonitis (PROPHYBIOM): a prospective multicentric randomized controlled trial
    Coccolini, F.
    Tarasconi, A.
    Petracca, G. L.
    Perrone, G.
    Giuffrida, M.
    Disisto, C.
    Sartelli, M.
    Carcoforo, P.
    Ansaloni, L.
    Catena, F.
    TRIALS, 2022, 23 (01)
  • [9] Effectiveness of Prophylactic Intraperitoneal Mesh Implantation for Prevention of Incisional Hernia in Patients Undergoing Open Abdominal Surgery A Randomized Clinical Trial
    Kohler, Andreas
    Lavanchy, Joel L.
    Lenoir, Ursina
    Kurmann, Anita
    Candinas, Daniel
    Beldi, Guido
    JAMA SURGERY, 2019, 154 (02) : 109 - 115
  • [10] Prophylactic Cholecystectomy is Safe in Patients Undergoing Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy
    Hanna, David N.
    Khajoueinejad, Nazanin
    Ghani, Muhammad O.
    Hermina, Andrew
    Mina, Alexander
    Bailey, Christina E.
    Cohen, Noah
    Labow, Daniel
    Golas, Benjamin
    Sarpel, Umut
    Idrees, Kamran
    Magge, Deepa
    AMERICAN SURGEON, 2024, 90 (06) : 1577 - 1581